First described as a transcript consistently downregulated in ovarian carcinoma22, the expression of Dab2 has been shown to be decreased in many cancer types including breast23, colorectal24, lung25, urothelial bladder26 and squamous cell carcinoma (SCC)27. Here, DAB2 is linked to cancer.